{{Rsnum
|rsid=472402
|Gene=SRD5A1
|Chromosome=5
|position=6635478
|Orientation=plus
|GMAF=0.4986
|Gene_s=SRD5A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 29.2 | 52.3 | 18.5
| HCB | 13.6 | 47.7 | 38.6
| JPT | 2.4 | 45.2 | 52.4
| YRI | 21.7 | 50.0 | 28.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.6 | 47.7 | 38.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=3E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}{{PMID Auto
|PMID=18603647
|Title=Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response.
|OA=1
}}